Health Care, News Now!

Scientists and policymakers debate delaying second vaccine dose

Is it wiser to hold back the second doses everyone will need, or to give as many people as possible a shot now? There are concerns due to a supply constraint. Only Pfizer and Moderna vaccines are authorized, even though policymakers had

Business, Health Care, Local News

European Medicines Agency validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) as adjuvant treatment for resected esophageal or gastroesophageal junction cancer following chemoradiotherapy

PRINCETON, N.J. — (BUSINESS WIRE) — $BMY #BMS—Bristol Myers Squibb (NYSE:BMY) today announced that the European Medicines Agency (EMA) validated its Marketing Authorization Application (MAA) for Opdivo (nivolumab) as an adjuvant treatment for esophageal or gastroesophageal junction (GEJ) cancer in adult patients